Overcoming Resistance to Platinum Therapy in Patients with Advanced Cancer

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.1, Iss.4, 2002-01, pp. : 247-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy

By Ioannidis Georgios Souglakos John Georgoulias Vassilis

Lung Cancer Management, Vol. 2, Iss. 4, 2013-08 ,pp. : 281-293

Future Medicine

Access to resources Recommend Favorite

Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFRT790M mutant lung cancer

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2063-2066

Spandidos Publications

Access to resources Recommend Favorite

Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 723-730

Spandidos Publications

Access to resources Recommend Favorite

TP53 oncomorphic mutations predict resistance to platinum and taxanebased standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 607-618

Spandidos Publications

Access to resources Recommend Favorite

Capecitabine as third line therapy in patients with advanced colorectal cancer

By Gubanski Michael Naucler Gisela Almerud Agneta Lideståhl Anders Lind Pehr A R M

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 236-239

Informa Healthcare

Access to resources Recommend Favorite